Download presentation
Presentation is loading. Please wait.
Published byΛάχεσις Ζωγράφου Modified over 5 years ago
1
Improving the safety of T-Cell therapies using an inducible caspase-9 gene
Xiaoou Zhou, Malcolm K. Brenner Experimental Hematology Volume 44, Issue 11, Pages (November 2016) DOI: /j.exphem Copyright © 2016 ISEH - International Society for Experimental Hematology Terms and Conditions
2
Figure 1 Structure of the iC9 suicide gene. (A) The transgene consists of an inducible caspase-9 (iC9) and a selectable marker, truncated CD19 (ΔCD19), linked by a 2A-like sequence, which encodes a cleavable peptide. iC9 consists of a drug-binding domain (FKBP12-F36V) connected via a short linker (SGGGS) to human caspase-9. (B) Conditional caspase 9 dimerization is induced in the presence of CID (AP1903), cleaving caspase-3 and leading to cell apoptosis. Experimental Hematology , DOI: ( /j.exphem ) Copyright © 2016 ISEH - International Society for Experimental Hematology Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.